Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Involvement of P2Y1 and P2Y11 Purinoceptors in Parasympathetic Inhibition of Colonic Smooth Muscle

Brian F. King and Andrea Townsend-Nicholson
Journal of Pharmacology and Experimental Therapeutics March 2008, 324 (3) 1055-1063; DOI: https://doi.org/10.1124/jpet.107.131169
Brian F. King
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Townsend-Nicholson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Purinergic signaling was first recognized in the guinea pig (Cavia porcellus) taenia coli, where relaxation of smooth muscle by nerve-released ATP may involve the activation of P2Y1 and P2Y11 receptors, and where transcripts for both genes have been found. A partial sequence for P2Y11 protein was identified; the full-length P2Y1 sequence has already been described. P2Y1 and P2Y11 proteins were localized by immunohistochemistry in smooth muscle cells. P2X2 and P2X3 proteins were also localized in motoneurons of the myenteric plexus. αβ-Methylene-ATP (αβmeATP) and dibenzoyl-ATP (BzATP) evoked fast relaxations in the taenia, and they were inhibited by the P2Y1 receptor antagonist 2′-deoxy-N6-methyladenosine 3′,5′-bisphosphate (MRS2179). However, αβmeATP and BzATP may stimulate neuronal P2X receptors to release ATP, which then acts on P2Y1 receptors. In accordance, fast relaxations evoked by αβmeATP and BzATP were inhibited by the P2X3 and P2X2/3 receptor antagonist 5-({[3-phenoxybenzyl][(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] amino} carbonyl)-1,2,4-benzene-tricarboxylic acid (A317491). When P2Y1, P2X3, and P2X2/3 receptors were blocked and adenosine was removed enzymatically, αβmeATP and BzATP evoked slow relaxations that were inhibited by Reactive Red. Fast and slow relaxations involve small and large conductance calcium-activated potassium channels; the latter are dependent on intracellular cyclic AMP levels, which altered the duration and amplitude of relaxations. αβmeATP and BzATP were confirmed as agonists, and Reactive Red as an antagonist, of human P2Y11 receptors. In summary, Gq-coupled P2Y1 receptors are involved mainly in fast relaxations, whereas Gqand Gs-coupled P2Y11 receptors are involved in both fast and slow relaxations. These P2Y receptor subtypes, plus neuronal P2X receptors, may explain the phenomenon of parasympathetic inhibition first described by Langley (1898).

Footnotes

  • A.T.-N. is funded by British Heart Foundation Grants FD/99049 and PG2001052.

  • Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

  • doi:10.1124/jpet.107.131169.

  • ABBREVIATIONS: SMC, smooth muscle cell; IJP, inhibitory junction potential; SKCa, small conductance calcium-activated potassium channel; BKCa, large conductance calcium-activated potassium channel; NO, nitric oxide; VIP, vasoactive intestinal peptide; PACAP, pituitary adenylyl cyclase-activating peptide; BzATP, dibenzoyl-ATP; αβmeATP, α,β-methylene-ATP; PCR, polymerase chain reaction; FLIPR, fluorometric imaging plate reader; C/R, concentration-response; DAPI, 4′,6-diamidino-2-phenylindole; MRS2179, 2′-deoxy-N6-methyladenosine 3′,5′-bisphosphate; A317491, 5-({[3-phenoxybenzyl][(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] amino} carbonyl)-1,2,4-benzene-tricarboxylic acid; ADA, adenosine deaminase; ISO, isoprenaline; Ro-20-1724, 4-(3-butoxy-4-methoxyphenyl)methyl-2-imidazolidone; PPADS, pyridoxal phosphate-6-azophenyl-2′,4′-disulfonic acid; ARC67085, 2-propylthio-βγCl2meATP; ir, immunoreactivity.

    • Received September 3, 2007.
    • Accepted November 28, 2007.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 382 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 382, Issue 3
1 Sep 2022
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Involvement of P2Y1 and P2Y11 Purinoceptors in Parasympathetic Inhibition of Colonic Smooth Muscle
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Involvement of P2Y1 and P2Y11 Purinoceptors in Parasympathetic Inhibition of Colonic Smooth Muscle

Brian F. King and Andrea Townsend-Nicholson
Journal of Pharmacology and Experimental Therapeutics March 1, 2008, 324 (3) 1055-1063; DOI: https://doi.org/10.1124/jpet.107.131169

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCELLULAR AND MOLECULAR

Involvement of P2Y1 and P2Y11 Purinoceptors in Parasympathetic Inhibition of Colonic Smooth Muscle

Brian F. King and Andrea Townsend-Nicholson
Journal of Pharmacology and Experimental Therapeutics March 1, 2008, 324 (3) 1055-1063; DOI: https://doi.org/10.1124/jpet.107.131169
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • N-stearoylethanolamine inhibits platelet reactivity
  • CsA Downregulates Selenop Expression via a STAT3-FoxO1 Axis
  • Anisodamine Ameliorates Acute Lung Injury
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics